A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice. Bleeding Thromb Vascul Biol [Internet]. 2022 May 23 [cited 2025 Jul. 28];1(2). Available from: https://www.btvb.org/btvb/article/view/19